Last updated on November 1, 2025
No. Germany does not permit individuals to receive hundreds of COVID-19 vaccine doses, even for scientific purposes, without strict clinical trial approval and ethics oversight. Such actions would violate national and EU research regulations designed to protect health and safety.
Science Meets Regulation
Germany takes research ethics seriously, especially when human health is involved. While the idea of someone rolling up their sleeve for 200 shots sounds like a bold experiment, the law says otherwise. Any study involving repeated vaccinations falls under the Medicinal Products Act (AMG) and EU Clinical Trials Regulation, requiring formal approval, risk assessment, and informed consent. This isn’t bureaucracy for bureaucracy’s sake—it’s about safeguarding participants and ensuring science doesn’t cross ethical boundaries.
The Federal Institute for Drugs and Medical Devices (BfArM) oversees clinical trials in Germany. Researchers must submit detailed protocols, justify the scientific necessity, and obtain clearance from an ethics committee. Without these steps, administering vaccines—even in the name of discovery—is illegal. The system is designed to prevent harm, especially given that vaccines, while life-saving, can cause adverse effects if misused.
Why the Limit Exists
COVID-19 vaccines were a triumph of modern science, but they’re not risk-free. The Paul-Ehrlich-Institut, Germany’s authority for vaccine safety, monitors side effects and publishes pharmacovigilance reports. These reports show that even rare complications matter when scaled up. Receiving hundreds of doses would exponentially increase risks like myocarditis or severe allergic reactions. That’s why Germany enforces strict dosage protocols, guided by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute.
STIKO recommends a basic immunity framework—three exposures to the virus or vaccine components, with boosters for vulnerable groups. Anything beyond that is considered outside medical necessity and enters the realm of experimental research, which triggers regulatory red flags.
Ethics at the Core
The German Ethics Council emphasizes that human dignity and bodily integrity are non-negotiable. Even during the pandemic, when urgency was high, ethics committees scrutinized every trial. The principle is clear: scientific progress cannot override individual rights. A study proposing 200 vaccine doses would need extraordinary justification, comprehensive risk mitigation, and participant consent under the EU Clinical Trials Regulation (Regulation (EU) No 536/2014).
Germany’s new Medical Research Act, currently under discussion, aims to streamline approvals but not dilute safeguards. It introduces specialized ethics committees for complex trials, reinforcing the commitment to ethical rigor.
When Reality Outpaces Rules
Despite these strict regulations, one extraordinary case made headlines: a 62-year-old man in Magdeburg reportedly received 217 COVID-19 vaccine doses over 29 months. Starting in mid-2021, he averaged a shot every few days, using multiple vaccine brands. Prosecutors investigated him for fraud but found no criminal charges. Later, researchers at Friedrich-Alexander University Erlangen-Nürnberg studied his immune response and published findings in The Lancet Infectious Diseases. Surprisingly, he showed no major side effects and remained COVID-free, with exceptionally high antibody and T-cell levels.
However, scientists stressed this is not a model for public health. Hypervaccination carries unknown long-term risks and violates medical guidelines. The case underscores why Germany’s legal framework exists: to prevent extreme, uncontrolled experiments that could endanger health and erode trust in science.
Practical and Cultural Context
Germany’s cautious approach reflects its historical lessons and cultural emphasis on trust in science. Vaccine campaigns succeeded because transparency and safety were prioritized. Allowing extreme experiments without oversight would undermine that trust. Moreover, public health law mandates proportionality—research must balance potential benefits against risks. In this case, the risks of 200 doses far outweigh any conceivable scientific gain.
The Bottom Line
Curiosity drives science, but in Germany, it must travel within legal and ethical lanes. Receiving hundreds of COVID-19 vaccines isn’t just medically questionable—it’s legally prohibited unless embedded in a rigorously approved clinical trial. The framework protects participants, preserves public confidence, and ensures that innovation never comes at the cost of human safety.
See more on GERMANY
Sources
Current information on coronavirus vaccination | BMG
https://www.bundesgesundheitsministerium.de/en/coronavirus/faq-covid-19-vaccination.html
Ongoing
BfArM – Clinical trials
https://www.bfarm.de/EN/Medicinal-products/Clinical-trials/_node.html
Ongoing
Safety of COVID-19 Vaccines – Paul-Ehrlich-Institut
https://www.pei.de/EN/newsroom/dossier/coronavirus/medicine-safety.html
Ongoing
Vaccination recommendations by STIKO – RKI
https://www.rki.de/EN/Topics/Infectious-diseases/Immunisation/STIKO/STIKO-recommendations/recommendations_content.html
Ongoing
Ethical Orientation on Mandatory Vaccination – German Ethics Council
https://www.ethikrat.org/en/publications/ad-hoc-recommendations/ethical-orientation-on-the-issue-of-general-mandatory-vaccination/
Dec 22, 2021
Case Study: Man received 217 COVID-19 vaccines – The Lancet Infectious Diseases
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00168-4/fulltext
Mar 2024